Cargando…
Interleukins 20 and 8 – less widely known cytokines in psoriasis
Psoriasis is a common immune-mediated inflammatory dermatosis affecting 2–3% of the northern European population. Although its aetiology is not completely elucidated, it is widely accepted that activated immune cells and keratinocytes stimulate keratinocyte hyperproliferation by production of cytoki...
Autores principales: | Kutwin, Magdalena, Woźniacka, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258704/ https://www.ncbi.nlm.nih.gov/pubmed/37312911 http://dx.doi.org/10.5114/ada.2022.119077 |
Ejemplares similares
-
An Analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R Expression and Their Correlation with Clinical Course in Patients with Psoriasis
por: Kutwin, Magdalena, et al.
Publicado: (2021) -
Are interleukin-15 and -22 a new pathogenic factor in pustular palmoplantar psoriasis?
por: Lesiak, Aleksandra, et al.
Publicado: (2016) -
Interleukin 22 and 6 serum concentrations decrease under long-term biologic therapy in psoriasis
por: Olejniczak-Staruch, Irmina, et al.
Publicado: (2020) -
Level of inflammatory cytokines tumour necrosis factor α, interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome
por: Pirowska, Magdalena, et al.
Publicado: (2019) -
Interleukin-17 cytokines: Effectors and targets in psoriasis—A breakthrough in understanding and treatment
por: Prinz, Immo, et al.
Publicado: (2019)